Quantitative Analysis of mRNA as a Marker for Viability of Mycobacterium tuberculosis
Open accessThe DOI matches its Crossref record.
Abstract
Numerous assays which use conserved DNA or rRNA sequences as targets for amplification have been described for the diagnosis of tuberculosis. However, these techniques have not been applied successfully to the monitoring of therapeutic efficacy owing to the persistence of amplifiable nucleic acid beyond the point at which smears and cultures become negative. Semiquantitative analysis of rRNA has been used to reduce the time required for antimicrobial susceptibility testing of Mycobacterium tuberculosis , although growth for up to 5 days in the presence of some drugs is still required to discriminate resistant strains. The purpose of the present study was to determine whether quantitative analysis of M. tuberculosis mRNA could be used to assess bacterial viability and to illustrate the application of this technique to rapid determination of drug susceptibility. Levels of mRNA encoding the 85B protein (α-antigen), IS 6110 DNA, and 16S rRNA were compared in parallel cultures of M. tuberculosis that were treated with either no drug, 0.2 μg of isoniazid per ml, or 1 μg of rifampin per ml. Exposure of sensitive strains to isoniazid or rifampin for 24 h reduced the levels of 85B mRNA to <4 and <0.01%, respectively, of those present in control cultures without drug. In contrast, the levels of IS 6110 DNA and 16S rRNA did not diminish over the same period. Strains which were resistant to either isoniazid or rifampin demonstrated no reduction in 85B mRNA in the presence of the drug to which they were nonresponsive. Quantitative analysis of 85B mRNA offers a potentially useful tool for the rapid determination of M. tuberculosis drug susceptibility and for the monitoring of therapeutic efficacy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Yang, S., & Rothman, R. E. (2004) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(04)01044-8 · Cited by 1,112
Homer, M. J., Aguilar-Delfin, I., Telford, S. R., Krause, P. J., & Persing, D. H. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.451 · Cited by 528
Molecular methods for the assessment of bacterial viability
Keer, J. T., & Birch, L. (2003) · Journal of Microbiological Methods · doi:10.1016/s0167-7012(03)00025-3 · Cited by 394
New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
Zumla, A. I., Gillespie, S. H., Hoelscher, M., Philips, P. P. J., Cole, S. T., Abubakar, I., McHugh, T. D., Schito, M., Maeurer, M., & Nunn, A. J. (2014) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(13)70328-1 · Cited by 342
Honoré-Bouakline, S., Vincensini, J. P., Giacuzzo, V., Lagrange, P. H., & Herrmann, J. L. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.6.2323-2329.2003 · Cited by 168
“By comparison, detection of RNA, as demonstrated in several elegant studies (11, 23, 24), might allow differentiation between latent bacilli and replicating bacilli in tissue samples.”
Metadata
- Authors
- Hellyer, T. J., DesJardin, L. E., Hehman, G. L., Cave, M. D., & Eisenach, K. D.
- Venue
- Journal of Clinical Microbiology
- Publisher
- American Society for Microbiology
- Published
- 1999-02
- Volume
- 37
- Issue
- 2
- Pages
- 290-295
- ISSN
- 0095-1137 (ISSN-L)
- 1098-660X
- OpenAlex
- W1899305737
- Cited by
- 134
- References
- 0
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Quantitative Analysis of mRNA as a Marker for Viability of Mycobacterium tuberculosis. https://app.cochat.ai/papers/10.1128/jcm.37.2.290-295.1999
- The paper
- Hellyer, T. J., DesJardin, L. E., Hehman, G. L., Cave, M. D., & Eisenach, K. D. (1999). Quantitative Analysis of mRNA as a Marker for Viability of Mycobacterium tuberculosis. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.37.2.290-295.1999
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.